CVE:ZMD

ZoomMed Competitors

C$0.02
+0.02 (+∞)
(As of 10/4/2018)
Add
Compare
Today's Range
C$0.02
Now: C$0.02
C$0.02
50-Day Range
C$0.02
MA: C$0.02
C$0.02
52-Week Range
C$0.01
Now: C$0.02
C$0.05
Volume220,000 shs
Average Volume290,486 shs
Market CapitalizationC$2.03 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

ZoomMed (CVE:ZMD) Vs. BLOX, SAAS, PKK, SPO, KNR, and GET

Should you be buying ZMD stock or one of its competitors? Companies in the sector of "computer and technology" are considered alternatives and competitors to ZoomMed, including (BLOX) (BLOX), (SAAS) (SAAS), 1411 (PKK), 16580 (SPO), 1661 (KNR), and 178110 (GET).

(BLOX) (CNSX:BLOX) and ZoomMed (CVE:ZMD) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Earnings and Valuation

This table compares (BLOX) and ZoomMed's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(BLOX)N/AN/AN/AN/AN/A
ZoomMedC$10,000.00203.39C$-1,491,501.00C($0.01)-1.36

(BLOX) has higher earnings, but lower revenue than ZoomMed.

Profitability

This table compares (BLOX) and ZoomMed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(BLOX)N/AN/AN/A
ZoomMedN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for (BLOX) and ZoomMed, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(BLOX)0000N/A
ZoomMed0000N/A

Summary

ZoomMed beats (BLOX) on 1 of the 1 factors compared between the two stocks.

(SAAS) (CNSX:SAAS) and ZoomMed (CVE:ZMD) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Earnings & Valuation

This table compares (SAAS) and ZoomMed's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(SAAS)N/AN/AN/AN/AN/A
ZoomMedC$10,000.00203.39C$-1,491,501.00C($0.01)-1.36

(SAAS) has higher earnings, but lower revenue than ZoomMed.

Profitability

This table compares (SAAS) and ZoomMed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(SAAS)N/AN/AN/A
ZoomMedN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings for (SAAS) and ZoomMed, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(SAAS)0000N/A
ZoomMed0000N/A

Summary

ZoomMed beats (SAAS) on 1 of the 1 factors compared between the two stocks.

ZoomMed (CVE:ZMD) and 1411 (CNSX:PKK) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk.

Analyst Ratings

This is a summary of recent recommendations and price targets for ZoomMed and 1411, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ZoomMed0000N/A
141101002.00

1411 has a consensus price target of $2.40, suggesting a potential upside of ∞. Given 1411's higher possible upside, analysts clearly believe 1411 is more favorable than ZoomMed.

Valuation & Earnings

This table compares ZoomMed and 1411's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZoomMedC$10,000.00203.39$-1,491,501.00C($0.01)-1.36
1411N/AN/AN/AN/AN/A

1411 has lower revenue, but higher earnings than ZoomMed.

Profitability

This table compares ZoomMed and 1411's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ZoomMedN/AN/AN/A
1411N/AN/AN/A

ZoomMed (CVE:ZMD) and 16580 (CNSX:SPO) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares ZoomMed and 16580's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ZoomMedN/AN/AN/A
16580N/AN/AN/A

Earnings & Valuation

This table compares ZoomMed and 16580's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZoomMedC$10,000.00203.39$-1,491,501.00C($0.01)-1.36
16580N/AN/AN/AN/AN/A

16580 has lower revenue, but higher earnings than ZoomMed.

Analyst Ratings

This is a breakdown of recent ratings and price targets for ZoomMed and 16580, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ZoomMed0000N/A
165800000N/A

Summary

ZoomMed beats 16580 on 1 of the 1 factors compared between the two stocks.

1661 (CNSX:KNR) and ZoomMed (CVE:ZMD) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Valuation & Earnings

This table compares 1661 and ZoomMed's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1661N/AN/AN/AN/AN/A
ZoomMedC$10,000.00203.39C$-1,491,501.00C($0.01)-1.36

1661 has higher earnings, but lower revenue than ZoomMed.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 1661 and ZoomMed, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
166100103.00
ZoomMed0000N/A

1661 currently has a consensus target price of C$6.74, suggesting a potential upside of ∞. Given 1661's higher possible upside, equities research analysts clearly believe 1661 is more favorable than ZoomMed.

Profitability

This table compares 1661 and ZoomMed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1661N/AN/AN/A
ZoomMedN/AN/AN/A

Summary

1661 beats ZoomMed on 2 of the 3 factors compared between the two stocks.

178110 (CNSX:GET) and ZoomMed (CVE:ZMD) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for 178110 and ZoomMed, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1781100000N/A
ZoomMed0000N/A

Profitability

This table compares 178110 and ZoomMed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
178110N/AN/AN/A
ZoomMedN/AN/AN/A

Valuation and Earnings

This table compares 178110 and ZoomMed's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
178110N/AN/AN/AN/AN/A
ZoomMedC$10,000.00203.39C$-1,491,501.00C($0.01)-1.36

178110 has higher earnings, but lower revenue than ZoomMed.

Summary

ZoomMed beats 178110 on 1 of the 1 factors compared between the two stocks.


ZoomMed Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BLOX
(BLOX)
0.4N/AN/A$0.00N/A0.00High Trading Volume
SAAS
(SAAS)
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
PKK
1411
1.1N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
SPO
16580
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
KNR
1661
1.2N/AN/AC$0.00N/A0.00High Trading Volume
GET
178110
0.6N/AN/A$0.00N/A0.00Gap Up
1mage Software logo
ISOL
1mage Software
0.7N/AN/A$0.00N/A0.00
TTM
6596 (TTM.V)
0.5$0.11+4.5%C$0.00N/A0.00
PHO
78790 (PHO.V)
0.9$2.28+0.9%C$0.00N/A0.00
ASTI
Ascent Solar Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
BNXA
Banxa
1.4$7.12+0.8%C$0.00N/A0.00
WIFI
Boingo Wireless
0.0N/AN/A$0.00N/A0.00High Trading Volume
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
ZKL
China Keli Electric
0.6$0.02+100.0%C$0.00N/A0.00Gap Down
Converge Technology Solutions Corp. (CTS.V) logo
CTS
Converge Technology Solutions Corp. (CTS.V)
1.2$6.45+4.5%C$0.00C$873.95 million-165.38Gap Down
DMGI
DMG Blockchain Solutions
0.5$2.01+0.5%C$0.00C$6.87 million-83.75Gap Down
FDM
Fandom Sports Media
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
FSD Pharma logo
HUGE
FSD Pharma
0.7N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
UAV
Global UAV Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
HP
Helmerich & Payne
1.4N/AN/A$0.00N/A0.00High Trading Volume
IGN
iShares North American Tech-Multimedia Networking ETF
0.8N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
NXT
Natcore Technology
0.5$0.06+100.0%C$0.00N/A-4.29Gap Down
NUR
Nuran Wireless
0.4N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
PAI
Predictiv AI
0.0$0.14+3.6%C$0.00C$162,949.00-2.22News Coverage
Gap Up
RIW
Riwi
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
GEL
Tangelo Games Corp. (GEL.V)
0.5$0.03+100.0%C$0.00C$34.00 million-0.09Gap Down
TER
Teradyne
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
VCT
Velocity Data
0.5N/AN/AC$0.00N/A0.00High Trading Volume
ZTE
Ztest Electronics
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.